Latest period
$1.94B
YoY change
+16.5%
5Y CAGR
-8.5%
Peak year (2020)
$3.60B
Latest annual
$2.31B
Cash on Hand history chart for Zoetis (ZTS) from 2010 to 2025
Latest: $2.31B
Cash on Hand growth chart for Zoetis (ZTS) from 2010 to 2025
Latest: +16.5%
Cash on Hand history table for Zoetis (ZTS) from 2010 to 2025
| 2025 | $2.31B | +16.5% | +$327.00M | ||
| 2024 | $1.99B | -2.6% | −$54.00M | ||
| 2023 | $2.04B | -43.0% | −$1.54B | ||
| 2022 | $3.58B | +2.7% | +$95.00M | ||
| 2021 | $3.48B | -3.3% | −$120.00M | ||
| 2020 | $3.60B | +86.4% | +$1.67B | ||
| 2019 | $1.93B | +13.9% | +$236.00M | ||
| 2018 | $1.70B | +8.4% | +$132.00M | ||
| 2017 | $1.56B | +115.1% | +$837.00M | ||
| 2016 | $727.00M | -37.0% | −$427.00M | ||
| 2015 | $1.15B | +30.8% | +$272.00M | ||
| 2014 | $882.00M | +44.6% | +$272.00M | ||
| 2013 | $610.00M | +92.4% | +$293.00M | ||
| 2012 | $317.00M | +301.3% | +$238.00M | ||
| 2011 | $79.00M | +25.4% | +$16.00M | ||
| 2010 | $63.00M | — | — |
- 2025$2.31B+16.5%
- 2024$1.99B-2.6%
- 2023$2.04B-43.0%
- 2022$3.58B+2.7%
- 2021$3.48B-3.3%
- 2020$3.60B+86.4%
- 2019$1.93B+13.9%
- 2018$1.70B+8.4%
- 2017$1.56B+115.1%
- 2016$727.00M-37.0%
- 2015$1.15B+30.8%
- 2014$882.00M+44.6%
- 2013$610.00M+92.4%
- 2012$317.00M+301.3%
- 2011$79.00M+25.4%
- 2010$63.00M—
Cash on Hand values are taken from Zoetis's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's latest reported cash and short-term investments is $1.94B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Zoetis (ZTS) cash and short-term investments totalled $2.31B – grew 16.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Zoetis cash and short-term investments compounded at -8.5% per year, with a net decline across the window.
Between 2020 and 2025, Zoetis cash and short-term investments plunged 35.8%, falling from $3.60B to $2.31B.
Across the available history, cash and short-term investments reached its high of $3.60B in 2020 and its low of $63.00M in 2010.
Zoetis Cash on Hand by Year
Zoetis Cash on Hand 2025: $2.31B
Zoetis posted cash and short-term investments of $2.31B in 2025, grew 16.5% from 2024.
Zoetis Cash on Hand 2024: $1.99B
In 2024, Zoetis reported cash and short-term investments of $1.99B, edged down 2.6% below 2023.
Zoetis Cash on Hand 2023: $2.04B
Zoetis cash and short-term investments in 2023 was $2.04B, plunged 43.0% below 2022.
Zoetis Cash on Hand 2022: $3.58B
2022's cash and short-term investments for Zoetis came in at $3.58B, edged up 2.7% from 2021.
Zoetis Cash on Hand 2021: $3.48B
Zoetis cash and short-term investments in 2021 was $3.48B.
See more financial history for Zoetis (ZTS).
Sector peers by Cash on Hand
Healthcare peers of Zoetis (ZTS), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation